Edition:
United States

ImmuCell Corp (ICCC.OQ)

ICCC.OQ on NASDAQ Stock Exchange Capital Market

6.64USD
11:03am EDT
Change (% chg)

$0.14 (+2.15%)
Prev Close
$6.50
Open
$6.64
Day's High
$6.64
Day's Low
$6.64
Volume
103
Avg. Vol
1,369
52-wk High
$9.25
52-wk Low
$5.29

Chart for

About

ImmuCell Corporation is an animal health company. The Company operates in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries segment. The Company has developed products that provide immediate immunity to newborn dairy and beef cattle,... (more)
No analyst recommendations are available for .

Overall

Beta: 1.42
Market Cap(Mil.): $36.61
Shares Outstanding(Mil.): 5.48
Dividend: --
Yield (%): --

Financials

  ICCC.OQ Industry Sector
P/E (TTM): -- 99.36 30.45
EPS (TTM): -0.21 -- --
ROI: -3.74 2.89 12.63
ROE: -4.76 1.65 14.82

BRIEF-ImmuCell Q1 Loss Per Share $0.04

* IMMUCELL ANNOUNCES FINANCIAL RESULTS FOR FIRST QUARTER OF 2018

May 14 2018

Competitors

  Price Chg
Merck & Co., Inc. (MRK.N) $69.95 +0.89
Pfizer Inc. (PFE.N) $42.44 +0.35
Eli Lilly And Co (LLY.N) $105.97 +0.42

Earnings vs. Estimates

No consensus analysis data available.